Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients With FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review

Cancers - Switzerland
doi 10.3390/cancers11070981
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Resectability After Neoadjuvant FOLFIRINOX in Locally Advanced Pancreatic Cancer: A Single-Center Experience

HPB
HepatologyGastroenterology
2016English

Neoadjuvant FOLFIRINOX for Patients With Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis

Oncologist
Cancer ResearchMedicineOncology
2019English

Folfirinox Neoadjuvant Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer - A Retrospective Study

International Journal of Contemporary Medical Research [IJCMR]
2019English

Systematic Review of FOLFIRINOX in Patients With Locally Unresectable Pancreatic Cancer

HPB
HepatologyGastroenterology
2016English

NeoadjuvantNab-paclitaxel and Gemcitabine in Borderline Resectable or Locally Advanced Unresectable Pancreatic Adenocarcinoma in Patients Who Are Ineligible for FOLFIRINOX

Anticancer Research
MedicineCancer ResearchOncology
2018English

Predictors for Resectability and Survival in Locally Advanced Pancreatic Cancer After Gemcitabine-Based Neoadjuvant Therapy

Pancreatology
EndocrinologyHepatologyMetabolismGastroenterologyDiabetes
2016English

A Patient-Level Meta-Analysis of FOLFIRINOX for Locally Advanced Pancreatic Cancer

HPB
HepatologyGastroenterology
2016English

Complete Pathological Response Following Neoadjuvant FOLFIRINOX in Borderline Resectable Pancreatic Cancer - A Case Report and Review

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

AB140. Efficacy of Radical Prostatectomy Combined With Neoadjuvant Chemotherapy in the Treatment of Locally Advanced Prostate Cancer: Preliminary Experiences From a Single Center

Translational Andrology and Urology
Reproductive MedicineUrology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy